Natco Pharma Ltd. | Mutual Funds
Mutual Funds that own Natco Pharma Ltd.
Nomura Asset Indian Investment Mother Fund
3,197,154
1.73%
1,906,138
0.98%
07/11/2017
Birla Sun Life Advantage Fund
2,526,197
1.37%
55,000
3.04%
07/31/2018
Matthews India Fund
2,096,417
1.13%
2,096,417
1.06%
06/29/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
1,701,566
0.92%
227,503
0%
03/31/2018
Jupiter India Fund
1,566,320
0.85%
13,937
1.4%
02/28/2018
Vanguard Emerging Markets Stock Index Fund
1,364,669
0.74%
-12,320
0.02%
07/31/2018
Nomura Asset India Equity Mother Fund
1,274,195
0.69%
834,583
1.38%
09/12/2017
Vanguard Total International Stock Index Fund
1,231,387
0.67%
0
0%
07/31/2018
Birla Sun Life '95 Fund
1,131,285
0.61%
0
0.73%
07/31/2018
Kotak Funds - India Mid Cap
1,009,772
0.55%
578,463
0.71%
12/31/2017
| Address |
NATCO House
Hyderabad TS 500034
India
|
|
Employees
|
- |
| Website |
http://www.natcopharma.co.in |
| Updated |
07/08/2019 |
| NATCO Pharma Ltd. engages in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations is a leading player in India's oncology segment with 28 active brands. |
